CD8A and neoplasm: In Figure 7(a,b), IHC results showed that chemotherapy using NPPA-PTX NPs and combination NPPA-PTX NPs/aPD-L1 both increased the number of CD3+, CD4+, and CD8+ T cells in tumor tissues, compared to the physiological saline treatment group.